Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Poorly Differentiated Thyroid Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Not applicableUnknownNCT04031339
What this trial is testing

Study of Clinical Outcomes of Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
University of Roma La Sapienza 15,000
Very early researchLooking for participantsNCT06639191
What this trial is testing

[177Lu]Lu-AKIR001 First-in-human Study

Who this might be right for
Thyroid Gland Anaplastic CarcinomaPoorly Differentiated Thyroid CarcinomaCancer Head and Neck+3 more
Karolinska University Hospital 15
Early research (Phase 1)Active Not RecruitingNCT04420754
What this trial is testing

Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer

Who this might be right for
Anaplastic Thyroid CancerRelapsed/Refractory Poorly Differentiated Thyroid Cancer
AffyImmune Therapeutics, Inc. 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT02152995
What this trial is testing

Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer

Who this might be right for
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland Carcinoma+9 more
National Cancer Institute (NCI) 34
Not applicableLooking for participantsNCT07068542
What this trial is testing

Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer

Who this might be right for
Advanced Thyroid CarcinomaRadioiodine-refractory Differentiated Thyroid CancerPoorly Differentiated Thyroid Carcinoma
Zhejiang Provincial People's Hospital 94
Very early researchStudy completedNCT00718770
What this trial is testing

A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression

Who this might be right for
Thyroid Cancer
University of Colorado, Denver 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04171622
What this trial is testing

Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer

Who this might be right for
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaStage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8+3 more
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Looking for participantsNCT07777536
What this trial is testing

Selective Coverage Versus Comprehensive Coverage Radiotherapy in Poorly Differentiated and Anaplastic Thyroid Cancer

Who this might be right for
Thyroid Cancer
Fudan University 72
Testing effectiveness (Phase 2)Ended earlyNCT03630120
What this trial is testing

Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer

Who this might be right for
Thyroid CancerThyroid Cancer, MedullaryDifferentiated Thyroid Cancer+3 more
H. Lee Moffitt Cancer Center and Research Institute 6
Not applicableStudy completedNCT01534897
What this trial is testing

Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436

Who this might be right for
Papillary Thyroid Carcinoma
Massachusetts General Hospital 10